The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals Limited, a public limited pharmaceutical company listed on NSE and BSE.Read More
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals Limited, a public limited pharmaceutical company listed on NSE and BSE.Read More